+57 Q&A - Equity Research 32 3mo
+43 How closely do you model your biotech names 10 2w
+41 Why do you want to be a sector-lead analyst? 13 3mo
+40 Lowest Comp You'd Take For Lead Coverage 25 8mo
+37 MD hates me, what do I do? 4 6mo
+35 Does anyone else find it very difficult to take vacations in ER? 5 4mo
+32 Q&A New Mentor | Senior Buyside Analyst – Equity Research, Healthcare Coverage & Breaking into the Buyside 8 7mo
+30 Struggling on my internship 5 3mo
+30 2025 ER Comp Thread 26 8mo
+28 Trading prestige for sanity…worth it? 6 11mo
+27 Integrating Claude into your process 3 2mo
+27 Finding a Way to Take the Series 86/87 Over the Summer 9 8mo
+26 Salary Expectations on Buyside/Sellside ER 21 9mo
+26 Equity Research to Corporate 5 9mo
+25 ER outlook 7 3mo
+25 Non-conventional exits from ER 4 11mo
+23 Incoming ER Associate - any tips/info/words of wisdom? 8 9mo
+22 Full-Time Equity Research Recruiting 5 3mo
+22 Started ER Internship, Reconsidering: Exit Opps? 15 3mo
+21 Sharing my Stock Pitch Report Project with y’all. 12 1mo
+21 Stock Pitch Support 7 9mo
+20 Article: UBS: The Fragile Facade of a Post-Merger Powerhouse 6 5mo
+18 Is Equity Research Still a Good Career Path in 2026? 20 2mo
+18 Former Pharma scientist with sell-side biotech ER experience — interview processes keep stalling, what am I missing 4 4mo
+18 ER Pulse Check... How We Doing? 6 5mo
+18 Is Biotech/Healthcare ER worth taking? 10 2mo
+18 Aside from an easier earnings season, why leave sell side for a LO? 7 7mo
+17 Equity Research Today: What skills are actually most valuable for entry-level analysts? 3 5mo
+16 How to handle call with DOR 5 1mo
+16 Is AI finally starting to kill Equity Research? 7 1mo
+16 Intel (INTC): My Bull Case Still Doesn't Justify the Current Stock Price 2 4mo
+16 Looking for help in choosing London Master’s degree 7 7mo
+16 How to approach interview with director of research 13 9mo
+15 How do you actually build your football fields — CapIQ, template, or from scratch? 11 3mo
+15 Built a desktop valuation app (DCF / DDM / reverse DCF) so I'd stop rebuilding Excel models for every pitch — would value some ER feedback 3 4mo
+15 ER Case Study guidance 1 6mo
+15 ER 27 Timeline 8 6mo
+15 What should I be reading? 5 7mo
+15 What to do? 6 8mo
+14 Deleted 9 1mo
+14 Deleted 9 2mo
+14 Pivot from Top European Engineering to Equity Research: Strategy Review 14 3mo
+14 How do you actually trace second-order effects after a market event? 7 3mo
+14 Rising junior at semi-target, fumbled sophomore recruiting — how cooked am I really? 8 5mo
+13 Is Equity Research Dying - Where Are the Future Opportunites? 4 16h
+13 Am I living in la la Land 3 1mo
+13 From BIG4 Audit to Equity/Credit Research -> how to break in 1 2mo
+13 ER--Unusually long reference checks post-superday 10 4mo
+13 Why does any firm issue a hold rating? 8 7mo
+13 Technicals to Focus on for ER? 12 10mo
+13 Ai is Infecting All of ER 6 11mo
+12 Bored on the buyside 1 6mo
+12 Texas ER work life? 3 6mo
+12 Outsourced IR firms 1 10mo
+11 Thoughts on boutique ER firm opportunity and options afterwards 2 4mo
+11 PayPal (PYPL): Why Is the Market Valuing PayPal Like a Low-Growth Company Despite Strong Free Cash Flow? 2 4mo
+11 How easy is it to switch sectors once you start your career 4 7mo
+11 ER interview with lead analyst 2 8mo
+11 Why should I choose to stay on the sellside? 6 8mo
+11 IM to ER FT Recruiting 4 9mo
+11 High-Efficiency Outsourcing New Infrastructure 2 9mo
+10 Associates who stuck around for > 5 years working for the same analyst. Why? 4 6d
+10 Which masters after Equity Research 4 3mo
+10 Automating Equity Research Workflows — From 2–3 Hours to ~20 Minutes 1 6mo
+10 What type of training is given to ER associates out of school versus lateral hires (untraditional backgrounds) 3 8mo
+10 MS ER SA 2027 proccess? 19 8mo
+10 Equity Sales - Exits? 7 9mo
+9 Detailed Revenue and Cost Builds 3 1w
+9 UBS ER SA27 Superday 7 3w
+9 Case-Study Assignment Take Home 1 1mo
+9 Sophomore, low semi-target, late start into finance recruiting. Feasible for equity research/credit research/risk? What technicals should I actually be learning right now? 4 3w
+9 Deleted 5 2mo
+9 Failing at recruiting - where from here? 1 2mo
+9 The Most Detailed Technical Breakdown of $MAAS: Five Months Later, Is the Party Over? 0 2mo
+9 what to buy at this point 0 2mo
+9 AI data centers are slamming head-on into the physical limits of the grid? 1 2mo
+9 Technical/Data Background → Semiconductor Equity Research: Built an AVGO Earnings Model and Would Appreciate ER Feedback 1 2mo
+9 Anyone recently interviewed for Bloomberg Intelligence Equity Research? 1 2mo
+9 VP shortlist at current shop vs. signed BB offer — thoughts? 1 2mo
+9 Who would you hire out of these two? 2 1mo
+9 What are the best paths into equity research through a life sciences undergrad? 1 2mo
+9 Rising Sophomore clueless about recruiting timeline 3 4mo
+9 Is equity research dead? If not, what aspects are still viable? 3 5mo
+9 CC student, help choose schools 3 5mo
+9 Notes from JBL's Q2 Earnings Call: Margins, Capex, and the FY27 Bridge 0 6mo
+9 IB SA -> ER 2 6mo
+9 Ford's CEO and CFO sounded exactly the same on the Q4 call. That's weird, right? 1 6mo
+9 Let go from LO cross-asset seat. How to position next move? 1 6mo
+9 Bloomberg Intelligence vs Sell-Side Equity Research → Buyside Path? 1 7mo
+9 Analyzing Distribution Patterns: Form 4 Outflows and Foundry Cycles 1 7mo
+9 are in-person channel checks for consumer companies useful 3 7mo
+9 What is the best path for me as MBA student to HF 3 5mo
+9 Institutional Capital Allocation: Decoding the Macro Shift Through Regulatory Disclosures 0 7mo
+9 Evaluating the Disconnect: Institutional Sentiment vs. C-Suite Capital Allocation in Discount Retail 1 7mo
+9 Hi! Interview for Research Associate position 1 7mo
+9 Appropriate discount rate for a taxable and nontaxable entity investing in the same project 1 7mo
+9 New Grad ER Associate -email from future boss about86/87. 4 8mo
+9 Replying to recruiter a week late… 2 8mo
+9 I want out. Where to go next? 2 9mo
+9 Neqd Wealth Circle: A Data-Driven View of U.S. Stocks 0 9mo

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
CompBanker's picture
CompBanker
98.9
8
dosk17's picture
dosk17
98.9
9
DrApeman's picture
DrApeman
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”